Crossmark

Finasteride or dutasteride for the pharmacological treatment for male lower urinary tract symptoms due to benign prostatic hyperplasia?

Crossref DOI link: https://doi.org/10.1016/j.acuroe.2016.02.011

Published Print: 2016-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Alcántara-Montero, A.

Brenes-Bermúdez, F.J.
License Information

Text and Data Mining valid from 2016-05-01
More Information

This article is maintained by: Elsevier

Article Title: Finasteride or dutasteride for the pharmacological treatment for male lower urinary tract symptoms due to benign prostatic hyperplasia?

Journal Title: Actas Urológicas Españolas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.acuroe.2016.02.011

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.acuro.2015.12.006

Content Type: simple-article

Copyright: © 2015 AEU. Published by Elsevier España, S.L.U. All rights reserved.